Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 2/2014

01.06.2014 | Original Article

Pharmacists’ contributions to the delivery of pharmaceutical care to patients with type 2 diabetes in Kuwait

verfasst von: Dalal M. Al-Taweel, Abdelmoneim I. Awad, B. Julienne Johnson

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to identify pharmacists’ potential contributions to the delivery of pharmaceutical care to patients with type 2 diabetes in Kuwait, and to identify and explore barriers that were preventing them from providing care to this specific group. A pretested self-administered questionnaire was distributed to all pharmacists registered in the Kuwait Pharmaceutical Association’s email registry (N = 250). Invitations to a focus group interview were then sent to all pharmacists (N = 50) who had responded to the questionnaire. Seven pharmacists accepted the invitation and participated in the focus group interview. Of the 50 respondents to the questionnaire, 31 (62.0 %; 95 % CI: 47.2–75.4) indicated that they were “comfortable” and “extremely comfortable” in discussing patient’s blood pressure target and annual screening with physicians rather than discussing smoking cessation advice or specific medication-related care issues. More than 75 % of the respondents were “comfortable” and “extremely comfortable” in sharing and verifying the patient’s drug history, blood pressure, cholesterol and stability of blood glucose with the healthcare team, and to maintain a pharmaceutical care plan for patients with diabetes. Overall, pharmacists indicated that they were more comfortable in undertaking clinical activities than discussing care issues with physicians. The focus group interview identified issues related to pharmacist-physician interaction, pharmacists’ confidence, pharmacists’ image by patients and physicians and barriers to implementing pharmaceutical care. This study shows that pharmacists in Kuwait perceive that their contribution to the delivery of pharmaceutical care could develop further with increased partnership between pharmacists and physicians and provision of further education, training and continuing professional development support.
Literatur
3.
Zurück zum Zitat Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj J. Known Type 2 diabetes mellitus among the Kuwaiti population: a prevalence study. Acta Diabetol. 1996;33:145–9.PubMedCrossRef Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj J. Known Type 2 diabetes mellitus among the Kuwaiti population: a prevalence study. Acta Diabetol. 1996;33:145–9.PubMedCrossRef
4.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012;32:11–63. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012;32:11–63.
5.
Zurück zum Zitat Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.PubMedCrossRef Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.PubMedCrossRef
6.
Zurück zum Zitat Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.PubMedCrossRef Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.PubMedCrossRef
7.
Zurück zum Zitat Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32.PubMedCrossRef Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32.PubMedCrossRef
8.
Zurück zum Zitat Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
9.
Zurück zum Zitat Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20:71–9.PubMedCrossRef Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20:71–9.PubMedCrossRef
10.
Zurück zum Zitat Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. AJHP. 2006;63:2144–50.PubMed Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. AJHP. 2006;63:2144–50.PubMed
11.
Zurück zum Zitat Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24:224–30.PubMedCrossRef Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24:224–30.PubMedCrossRef
12.
Zurück zum Zitat Al-Arifi M, Al-Dhuwaili A, Gubara O, Al-Omar H, Al-Sultan M, Saeed R. Pharmacists’ understanding and attitudes towards pharmaceutical care in Saudi Arabia. Saudi Pharm J. 2007;15:146–59. Al-Arifi M, Al-Dhuwaili A, Gubara O, Al-Omar H, Al-Sultan M, Saeed R. Pharmacists’ understanding and attitudes towards pharmaceutical care in Saudi Arabia. Saudi Pharm J. 2007;15:146–59.
13.
Zurück zum Zitat Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9:149–57.PubMed Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9:149–57.PubMed
15.
Zurück zum Zitat Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. 2nd ed. Thousand Oaks: Sage Publications; 1994. Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. 2nd ed. Thousand Oaks: Sage Publications; 1994.
16.
Zurück zum Zitat Al-Taweel DM, Awad AI, Johnson BJ. Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait. Int J Clin Pharm. 2013;35:244–50.PubMedCrossRef Al-Taweel DM, Awad AI, Johnson BJ. Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait. Int J Clin Pharm. 2013;35:244–50.PubMedCrossRef
17.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care. 2008;31:12–54. American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care. 2008;31:12–54.
18.
Zurück zum Zitat Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88–136.PubMedCrossRef Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88–136.PubMedCrossRef
19.
Zurück zum Zitat Scottish Intercollegiate Guidelines Network. Heart diseases. Edinburgh: SIGN; 2007. p. 93–7. Scottish Intercollegiate Guidelines Network. Heart diseases. Edinburgh: SIGN; 2007. p. 93–7.
20.
Zurück zum Zitat National Institute for Health and Clinical Excellence. The management of type 2 diabetes. UK: NICE; May 2008. National Institute for Health and Clinical Excellence. The management of type 2 diabetes. UK: NICE; May 2008.
21.
Zurück zum Zitat Power A, McKellar S, Hudson S. A consensus model for delivery of structured pharmaceutical care for the patient with type 2 diabetes mellitus by Scottish community pharmacists. Int J Pharm Pract. 2007;15:283–90.CrossRef Power A, McKellar S, Hudson S. A consensus model for delivery of structured pharmaceutical care for the patient with type 2 diabetes mellitus by Scottish community pharmacists. Int J Pharm Pract. 2007;15:283–90.CrossRef
22.
Zurück zum Zitat Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475–85. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475–85.
23.
Zurück zum Zitat Douglas EC, Power A, Hudson SA. Pharmaceutical care of the patient with diabetes mellitus: pharmacists’ priorities for services and educational needs in Scotland. Int J Pharm Pract. 2007;15:47–52.CrossRef Douglas EC, Power A, Hudson SA. Pharmaceutical care of the patient with diabetes mellitus: pharmacists’ priorities for services and educational needs in Scotland. Int J Pharm Pract. 2007;15:47–52.CrossRef
24.
Zurück zum Zitat Smith F. Health services research methods in pharmacy: focus groups and observation studies. Int J Pharm Pract. 1998;6:229–42.CrossRef Smith F. Health services research methods in pharmacy: focus groups and observation studies. Int J Pharm Pract. 1998;6:229–42.CrossRef
25.
Zurück zum Zitat Kitzinger J. The methodology of focus groups: the importance of interaction between research participants. Sociol Health. 1994;16:103–21.CrossRef Kitzinger J. The methodology of focus groups: the importance of interaction between research participants. Sociol Health. 1994;16:103–21.CrossRef
26.
Zurück zum Zitat Simpson SH, Farris KB, Johnson JA, Tsuyuki RT. Using focus groups to identify barriers to drug use in patients with congestive heart failure. Pharmacotherapy. 2000;20:823–9.PubMedCrossRef Simpson SH, Farris KB, Johnson JA, Tsuyuki RT. Using focus groups to identify barriers to drug use in patients with congestive heart failure. Pharmacotherapy. 2000;20:823–9.PubMedCrossRef
27.
Zurück zum Zitat Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
28.
29.
Zurück zum Zitat Kitzinger J. Focus groups with users and providers of health care. In: Pope C, Mays N, editors. Qualitative research in health care. 2nd ed. London: BMJ Books; 2000. Kitzinger J. Focus groups with users and providers of health care. In: Pope C, Mays N, editors. Qualitative research in health care. 2nd ed. London: BMJ Books; 2000.
30.
Zurück zum Zitat Matowe L, Abahussain EA, Al-Saffar N, Bihzad SM, Al-Foraih A, Al-Kandery AA. Physicians’ perceptions and expectations of pharmacists’ professional duties in government hospitals in Kuwait. Med Princ Pract. 2006;15:185–9.PubMedCrossRef Matowe L, Abahussain EA, Al-Saffar N, Bihzad SM, Al-Foraih A, Al-Kandery AA. Physicians’ perceptions and expectations of pharmacists’ professional duties in government hospitals in Kuwait. Med Princ Pract. 2006;15:185–9.PubMedCrossRef
31.
Zurück zum Zitat Grainger-Rousseau TJ, Miralles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc. 1997;NS37:647–61. Grainger-Rousseau TJ, Miralles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc. 1997;NS37:647–61.
33.
Zurück zum Zitat Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med. 1999;159:1939–45.PubMedCrossRef Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med. 1999;159:1939–45.PubMedCrossRef
34.
Zurück zum Zitat Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacists participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.PubMedCrossRef Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacists participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.PubMedCrossRef
35.
Zurück zum Zitat Wallgren S, Berry-Cabán CS, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Ann Pharmacother. 2012;46:353–7.PubMedCrossRef Wallgren S, Berry-Cabán CS, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Ann Pharmacother. 2012;46:353–7.PubMedCrossRef
36.
Zurück zum Zitat Hughes CM, McCan S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53:600–6.PubMedCentralPubMed Hughes CM, McCan S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53:600–6.PubMedCentralPubMed
37.
Zurück zum Zitat Van Mil J, de Boer W, Tromp T. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract. 2001;9:163–8.CrossRef Van Mil J, de Boer W, Tromp T. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract. 2001;9:163–8.CrossRef
38.
Zurück zum Zitat Lin AC, Jang R, Sedani D, Thomas S, Barker KN, Flynn EA. Re-engineering a pharmacy work system and layout to facilitate patient counselling. Am J Health Syst Pharm. 1996;53:158–64. Lin AC, Jang R, Sedani D, Thomas S, Barker KN, Flynn EA. Re-engineering a pharmacy work system and layout to facilitate patient counselling. Am J Health Syst Pharm. 1996;53:158–64.
39.
Zurück zum Zitat Ilieva J, Baron S, Healey NM. Online surveys in marketing research: pros and cons. Int J Mark Res. 2002;44:361–76. Ilieva J, Baron S, Healey NM. Online surveys in marketing research: pros and cons. Int J Mark Res. 2002;44:361–76.
Metadaten
Titel
Pharmacists’ contributions to the delivery of pharmaceutical care to patients with type 2 diabetes in Kuwait
verfasst von
Dalal M. Al-Taweel
Abdelmoneim I. Awad
B. Julienne Johnson
Publikationsdatum
01.06.2014
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 2/2014
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-013-0169-4

Weitere Artikel der Ausgabe 2/2014

International Journal of Diabetes in Developing Countries 2/2014 Zur Ausgabe